MedTrace Logo

Dermatitis Herpetiformis Refractory to Gluten Free Diet

NCT05998291 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2023-08-22

No results posted yet for this study

Summary

The main purpose of the study is to find out

1. the natural course of refractory dermatitis herpetiformis and the development of possible complications
2. the strictness of gluten-free diet treatment in refractory dermatitis herpetiformis

Conditions

  • Dermatitis Herpetiformis

Interventions

OTHER

Assessment of prognosis of refractory dermatitis herpetiformis. No intervention

Assessment of prognosis of refractory dermatitis herpetiformis. No intervention

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Kaisa Hervonen, PhD · Tampere University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05998291 on ClinicalTrials.gov